Erythroblasts as a parameter for mortality in critical ill patients supported with extacorporeal membrane oxygenation. A retrospective study

Erythroblasts as a parameter for mortality in critical ill patients supported with extacorporeal membrane oxygenation. A retrospective study - ECBLAS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023626

Enrollment

Registered

2020-12-10

Start date

2020-10-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R57.0 J80

Interventions

Group 1: Erythroblasts in critical ill patients with ECMO

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All critical ill patients supported with ECMO for more than 48 hours were permitted.

Exclusion criteria

Exclusion criteria: Critical ill patients supported with ECMO for less than 48 hours were excluded.

Design outcomes

Primary

Measure	Time frame
Evaluation of erythroblasts in blood samples of critical ill patients with ECMO as a parameter for mortality	—

Secondary

Measure	Time frame
28 days mortality	—

Countries

Germany

Contacts

Public ContactSebastian Loesaus

Universitätsklinik Bergmannsheil

sebastian.loesaus@bergmannsheil.de02343023495

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 10, 2026